 | This is a user sandbox of GiannaMissano. You can use it for testing or practicing edits. This is not the sandbox where you should draft your assigned article for a dashboard.wikiedu.org course. To find the right sandbox for your assignment, visit your Dashboard course page and follow the Sandbox Draft link for your assigned article in the My Articles section. |
Dr. Azra Raza’s career took off at the University of Massachusetts. At this university she was the chief of Hematology oncology as well as the Gladys Smith Martin professor of oncology. (New York- Presbyterian, 2015) Her work with laboratory research and clinical trials appeared in scientific journals. Some of the prestigious journals her work is published in include the New England Journal of Medicine, Nature, Cancer, and the British Journal of Hematology. She also reviews on these panels and serves as a consultant and advisor. She has board certifications in Medical oncology and internal medicine. Her work focuses on Acute Myelogenous,
,
- REDIRECT Leukemia
/ AML, Aplastic Anemia and others. (New York- Presbyterian, 2015) Not only does she serve on panels, have Board certifications and is a director and professor at Columbia University, but she has also received many award for her strenuous hours working. (New York- Presbyterian, 2015) Some of these awards are The Hope Award in Cancer Research in 2012, and the Award in Academic Excellence, which she won in 2007 and 2010. (New York- Presbyterian, 2015) Now Dr. Raza is a director of the MDS center at Columbia University and a Professor of Medicine. She began her time at Columbia in 2010. One of Dr. Raza’s Patients, Radhey khanna had little hope left with his fight with Myelodysplatic syndrome
until he met Dr. Raza. Dr. Raza introduced him to an experimental trial. This trial uses the drug
- REDIRECT thalidomide
to try and treat leprosy and
- REDIRECT multiple Myeloma
. (Elizabeth Cooney, 2005) One concern with this drug is that is can cause severe birth defects or even death of the unborn child in both pregnant and non-pregnant women. (Pr Newswire, 2000) For Mr. Khanna the treatment of Thalidomide was a success. He can now walk again. While his disease is not cured, the drug has arrested this disease in his body and he can now golf and participate in more activities than before the treatment. Since Mr. Khanna is an avid believer in Dr. Raza’s work, he pledged $1 million to Dr. Raza’s research. (Elizabeth Cooney, 2005) With this money, Dr. Raza plans to open a new center to examine natural substances to possibly prevent and treat cancer. She plans to develop non-toxic therapies in replacement of chemo. (Elizabeth Cooney, 2005)
- ^ New York Presbyterian June 26,2015 Columbia University Medical Center Herbert Irving Comprehensive Cancer Center (Physician’s profile) http://cancer.columbia.edu/azra-raza-md
- ^ Elizabeth Cooney Telegram and Gazette Staff July 18, 2005 Doctor’s dedication prompts patient’s gift $1 million pledge to support Dr. Raza’s researcher https://search-proquest-com.muhlenberg.idm.oclc.org/northeastnews1/docview/268935318/FC80EE1127D549C2PQ/1?accountid=40980</
- ^ Pr Newswire, NewYork , New York Study results on the use of Celgene’s Thalomid(R)(Thalidomide) as treatment for Myelodysplastic Syndrome NY December 6,2000 https://search-proquest-com.muhlenberg.idm.oclc.org/northeastnews1/docview/444272665/FC80EE1127D549C2PQ/2?accountid=40980</